Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kineta Inc KANT

Healthcare Biotechnology
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance: immunosuppression, exhausted T cells and poor tumor immunogenicity. Its pipeline of immunotherapies includes KVA12123, which is a... see more

Recent & Breaking News (OTCPK:KANT)

24 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  March 13, 2018

A Peek Into The Markets: U.S. Stock Futures Gain; Consumer Price Index In Focus

Benzinga.com  March 13, 2018

8 Stocks To Watch For March 13, 2018

Benzinga.com  March 13, 2018

6 Stocks Moving In Monday's After-Hours Session

Benzinga.com  March 12, 2018

26 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  March 9, 2018

Proteostasis Therapeutics to Present at the Cowen and Company 38th Annual Health Care Conference

GlobeNewswire March 7, 2018

Proteostasis Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

GlobeNewswire February 8, 2018

Proteostasis’ Proprietary Triple Combination Therapy Study Protocol Receives Endorsement and High Strategic Fit Score from the Largest Cystic Fibrosis Patient Advocacy Groups in the U.S. and Europe

GlobeNewswire January 8, 2018

Proteostasis Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire December 21, 2017

Proteostasis Therapeutics, Inc. (Nasdaq:PTI) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire December 15, 2017

Proteostasis Therapeutics Prices Public Offering of Common Stock

GlobeNewswire December 13, 2017

40 Biggest Movers From Yesterday

Benzinga.com  December 13, 2017

7 Stocks To Watch For December 13, 2017

Benzinga.com  December 13, 2017

8 Stocks Moving In Tuesday's After-Hours Session

Benzinga.com  December 12, 2017

Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire December 12, 2017

30 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  December 12, 2017

30 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  December 12, 2017

Proteostasis Therapeutics Announces Positive Clinical Results from Studies of PTI-428, PTI-801 and PTI-808 in Healthy Volunteers and Patients with Cystic Fibrosis

GlobeNewswire December 11, 2017

Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update

GlobeNewswire November 14, 2017

Proteostasis Therapeutics Focuses on Research and Development of CF Drug Candidates and Astellas Pharma Collaboration Programs

GlobeNewswire October 31, 2017